Todd Druley

Company: Mission Bio

Job title: Chief Medical Officer

Seminars:

High-risk Minor Subclones are Important for Prognosis in Multiple Myeloma 12:25 pm

Some HR abnormalities such as del17p, del1p32, or 1q gains are subclonal, and not detectable on bulk analysis These subclones might be selected early during induction therapy Single-cell analyses are mandatory to detect them at diagnosis to adapt treatmentRead more

day: Day One Track A AM